Paul Fitzsimmons

Effects of fluoxetine on functional outcomes after acute stroke (FOCUS): a pragmatic, double-blind, randomised, controlled trial

Martin Dennis, Gillian Mead, John Forbes et al. · The Lancet · 2018 · 276 citations · Full text

Effects of antiplatelet therapy after stroke due to intracerebral haemorrhage (RESTART): a randomised, open-label trial

Rustam Al‐Shahi Salman, M. J. S. Dennis, PAG Sandercock et al. · The Lancet · 2019 · 188 citations · Full text

Effects of antiplatelet therapy on stroke risk by brain imaging features of intracerebral haemorrhage and cerebral small vessel diseases: subgroup analyses of the RESTART randomised, open-label trial

Rustam Al‐Shahi Salman, David Minks, Dipayan Mitra et al. · The Lancet Neurology · 2019 · 88 citations · Full text

A Readability Assessment of Online Stroke Information

Nikhil Sharma, Andreas Tridimas, Paul Fitzsimmons · Journal of Stroke and Cerebrovascular Diseases · 2014 · 56 citations

Reliability, Stroke Rehabilitation, Assistive Technology +9

Older participants are frequently excluded from Parkinson's disease research

Paul Fitzsimmons, S. Blayney, S. Mina-Corkill et al. · Parkinsonism & Related Disorders · 2012 · 48 citations

Neurodegenerative Diseases, Geriatrics, Parkinson Disease +6